Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H11N3 |
| Molecular Weight | 197.2358 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CC#N)NC(=N1)C2=CC=CC=C2
InChI
InChIKey=OTRQRKIYHATFKM-UHFFFAOYSA-N
InChI=1S/C12H11N3/c1-9-11(7-8-13)15-12(14-9)10-5-3-2-4-6-10/h2-6H,7H2,1H3,(H,14,15)
| Molecular Formula | C12H11N3 |
| Molecular Weight | 197.2358 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1122930Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/3999024 | https://www.ncbi.nlm.nih.gov/pubmed/3749246
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1122930
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/3999024 | https://www.ncbi.nlm.nih.gov/pubmed/3749246
Mefenidil has been reported to be a selective cerebral vasodilator. It significantly increased cerebral blood flow (without stimulation of O2 uptake) and lowered cerebral vascular resistance without having significant effects in other circulatory regions. Increase in cerebral blood flow is not mediated via the beta-adrenergic receptor as the effect was not blocked by propranolol. However, the clinical usefulness of mefenidil as a cerebral vasodilator may be limited by the accompanying arterial hypotension due to systemic vasodilation, which was most prominent in heart and gut.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of mefenidil hydrochloride on cerebral blood flow in conscious and anesthetized rat. | 1986 |
|
| Effect of mefenidil on cerebral and peripheral hemodynamics in dogs. | 1985-05 |
|
| Cardiovascular profile of 5-methyl-2-phenyl-4-imidazole-acetonitrile (MCN-2378), a cerebral vasodilator. | 1975-01 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1122930
Curator's Comment: McN-2378 caused a more pronounced effect on cerebral blood flow than on femoral blood flow at the 2.5 and 5.0 mg/kg i.v. doses and this effect was significantly more prolonged at these doses.
Rhesus monkey: 2.5-5.0 mg/kg
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:33:02 GMT 2025
by
admin
on
Mon Mar 31 18:33:02 GMT 2025
|
| Record UNII |
74WY8560J7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000081458
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY | |||
|
5268
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY | |||
|
74WY8560J7
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY | |||
|
SUB08704MIG
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY | |||
|
DTXSID70206991
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY | |||
|
65475
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106836
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY | |||
|
T-14
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY | |||
|
58261-91-9
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY | |||
|
C66072
Created by
admin on Mon Mar 31 18:33:02 GMT 2025 , Edited by admin on Mon Mar 31 18:33:02 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |